Skip to Content

SI-BONE Inc SIBN

Morningstar Rating
$16.61 +0.05 (0.30%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SIBN is trading at a 831% premium.
Price
$16.60
Fair Value
$37.89
Uncertainty
High
1-Star Price
$96.22
5-Star Price
$64.80
Economic Moat
Bfzl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SIBN is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$16.56
Day Range
$16.3416.63
52-Week Range
$11.7626.03
Bid/Ask
$15.58 / $22.50
Market Cap
$684.41 Mil
Volume/Avg
226,468 / 364,840

Key Statistics

Price/Earnings (Normalized)
Price/Sales
4.60
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
344

Comparables

Valuation

Metric
SIBN
MMSI
NARI
Price/Earnings (Normalized)
27.23589.82
Price/Book Value
4.124.017.12
Price/Sales
4.603.896.07
Price/Cash Flow
21.90126.70
Price/Earnings
SIBN
MMSI
NARI

Financial Strength

Metric
SIBN
MMSI
NARI
Quick Ratio
8.634.222.09
Current Ratio
9.766.032.71
Interest Coverage
−13.626.17−98.60
Quick Ratio
SIBN
MMSI
NARI

Profitability

Metric
SIBN
MMSI
NARI
Return on Assets (Normalized)
−7.83%9.17%2.99%
Return on Equity (Normalized)
−10.72%15.14%3.92%
Return on Invested Capital (Normalized)
−10.92%10.93%1.60%
Return on Assets
SIBN
MMSI
NARI
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
SyzkwqysHfzhcv$177.5 Bil
Stryker Corp
SYK
RjxzvlrdlFnyh$129.9 Bil
Boston Scientific Corp
BSX
CmsgzmmtwChznw$114.0 Bil
Medtronic PLC
MDT
PdbhzrgtZhsxhp$101.9 Bil
Edwards Lifesciences Corp
EW
NprrwzlbsDrqpfbx$52.1 Bil
DexCom Inc
DXCM
KnpgdllkbMhjd$44.2 Bil
Koninklijke Philips NV ADR
PHG
HkgwnqtpjYmpzgfg$24.3 Bil
Zimmer Biomet Holdings Inc
ZBH
KbwwzgcbxVbm$22.7 Bil
Steris PLC
STE
XfwwjwkfjFxbssl$22.2 Bil
Align Technology Inc
ALGN
ZsxkjwfcqFbyjdv$18.9 Bil

Sponsor Center